HomeCompareHNHAF vs JNJ

HNHAF vs JNJ: Dividend Comparison 2026

HNHAF yields 5.80% · JNJ yields 2.13%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 HNHAF wins by $204.4K in total portfolio value
10 years
HNHAF
HNHAF
● Live price
5.80%
Share price
$3.26
Annual div
$0.19
5Y div CAGR
37.6%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$234.7K
Annual income
$98,005.75
Full HNHAF calculator →
JNJ
Johnson & Johnson
● Live price
2.13%
Share price
$244.44
Annual div
$5.20
5Y div CAGR
28%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.3K
Annual income
$4,689.40
Full JNJ calculator →

Portfolio growth — HNHAF vs JNJ

📍 HNHAF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodHNHAFJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, HNHAF + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
HNHAF pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

HNHAF
Annual income on $10K today (after 15% tax)
$492.62/yr
After 10yr DRIP, annual income (after tax)
$83,304.89/yr
JNJ
Annual income on $10K today (after 15% tax)
$180.82/yr
After 10yr DRIP, annual income (after tax)
$3,985.99/yr
At 15% tax rate, HNHAF beats the other by $79,318.90/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of HNHAF + JNJ for your $10,000?

HNHAF: 50%JNJ: 50%
100% JNJ50/50100% HNHAF
Portfolio after 10yr
$132.5K
Annual income
$51,347.58/yr
Blended yield
38.75%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

HNHAF
No analyst data
Altman Z
2.7
Piotroski
6/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
-6.4% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

HNHAF buys
0
JNJ buys
0
No recent congressional trades found for HNHAF or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricHNHAFJNJ
Forward yield5.80%2.13%
Annual dividend / share$0.19$5.20
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR37.6%28%
Portfolio after 10y$234.7K$30.3K
Annual income after 10y$98,005.75$4,689.40
Total dividends collected$197.7K$15.4K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: HNHAF vs JNJ ($10,000, DRIP)

YearHNHAF PortfolioHNHAF Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$11,497$797.47$10,592$272.30+$905.00HNHAF
2$13,481$1,179.10$11,289$357.73+$2.2KHNHAF
3$16,203$1,777.94$12,123$472.89+$4.1KHNHAF
4$20,085$2,747.98$13,141$629.86+$6.9KHNHAF
5$25,872$4,380.54$14,408$846.81+$11.5KHNHAF
6$34,939$7,256.24$16,021$1,151.60+$18.9KHNHAF
7$49,986$12,601.76$18,122$1,588.22+$31.9KHNHAF
8$76,671$23,185.05$20,930$2,228.20+$55.7KHNHAF
9$127,769$45,731.86$24,792$3,191.91+$103.0KHNHAF
10$234,719$98,005.75$30,274$4,689.40+$204.4KHNHAF

HNHAF vs JNJ: Complete Analysis 2026

HNHAFStock

Hon Hai Precision Industry Co., Ltd. provides technology solutions in Japan, Ireland, the United States, Singapore, China, Taiwan, and internationally. The company manufactures, sells, and services connectors, cases, thermal modules, wired/wireless communication products, optical products, power supply modules, and assemblies for use in the information technology, communications, automotive equipment, precision molding, automobile, and consumer electronics industries. It also manufactures and sells computer terminal monitors and related components, as well as data storage and processing equipment; offers solutions for autonomous driving systems, new energy power, and IoV systems; and provides services of planning, advisory, and business operation and management, logistics, export processing, construction, leasing, and information/software services. In addition, the company manufactures and sells application modules and network cables assemblies; develops educational technology; holds patent applications; manufactures and trades in portable cameras; and retails office machinery and equipment, and electronic appliances. Further, it is involved in the reinvestment in the businesses relating to robots, automatic equipment, molds, parts, and accessories and corresponding services; and software development, repair and after-sale, and rental services of robots. Additionally, the company manufactures and sells computer and data processing equipment, WIFI cards and modules, CFTVs, DVRs, Bluetooth modules, set-top boxes, and optical network terminals. It is also involved in the provision of data storage services; manufacturing of wire or wireless communication; installation of computer and satellite TV channels; and provision of mobile phone services, as well as telecom-related business. The company was founded in 1974 and is headquartered in New Taipei City, Taiwan.

Full HNHAF Calculator →

JNJHealthcare

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.

Full JNJ Calculator →
📬

Get this HNHAF vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

HNHAF vs SCHDHNHAF vs JEPIHNHAF vs OHNHAF vs KOHNHAF vs MAINHNHAF vs ABBVHNHAF vs MRKHNHAF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.